Breakthroughs in identifying tumor biomarkers in liver, gastric, prostate, lung and other cancers and are accelerating ...

Toronto, Ontario—Combination of alpha- and beta-radionuclide therapy is feasible, tolerable, and effective for colorectal cancer, according to preclinical research presented at the 2024 Society of ...

Transaxial slices of baseline positron emission tomography (PET) and fused PET/magnetic resonance imaging (MRI; left) demonstrate a somatostatin receptor-expressing meningioma in the left cavernous ...

To help guide clinicians in the evaluation of suspected cardiovascular infections, including infective endocarditis (IE) and others, the American Society of Nuclear Cardiology (ASNC) and 10 other ...

A team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, obtained through a simple blood test, can predict the clinical progression ...

Click on the 'Visit E-Learning Course' button on the top. Sign in with your NUCLEUS account, then click on 'Enrol me' on the bottom. If you do not have a NUCLEUS account, please register here first.

There are currently several different FDA approved radiopharmaceuticals being used in both large academic and small practice settings to accurately stage and identify local and metastatic prostate ...

The IAEA has recently published the Nuclear Medicine Physics Handbook, which is intended for teachers, students and residents involved in medical physics programmes, and aspiring to serve as primary ...

South African miner Sibanye-Stillwater and the South African Nuclear Energy Corporation (Necsa) will collaborate to further research the radioactive rhodium-based palladium isotope, with the aim of ...